Tenet Healthcare (NYSE:THC) PT Raised to $98.00 at The Goldman Sachs Group

Tenet Healthcare (NYSE:THC – Free Report) had its price objective increased by The Goldman Sachs Group from $89.00 to $98.00 in a research note issued to investors on Monday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other research analysts also recently issued reports on the company. […]

Related Keywords

Canada ,Paolam Arbour ,Raymond James ,Tenet Healthcare Corporation ,Goldman Sachs Group ,Eversource Wealth Advisors ,Global Retirement Partners ,Jpmorgan Chase Co ,Securities Exchange Commission ,Northwestern Mutual Wealth Management Co ,Citigroup ,Tenet Healthcare ,Tenet Healthcare Company Profile ,Royal Bank ,Householder Group Estate Retirement Specialist ,Free Report ,Healthcare Trading Down ,Get Free Report ,Exchange Commission ,Retirement Partners ,Group Estate ,Retirement Specialist ,Mutual Wealth Management ,Source Wealth Advisors ,Healthcare Corporation ,Hospital Operations ,Ambulatory Care ,Tenet Healthcare Daily ,Nyse Thc ,Thc ,Medical ,88033g40 ,Boost Price Target ,The Goldman Sachs Group Inc ,